Trader consensus implies an 88.5% probability of no new pandemic in 2026, anchored by the World Health Organization's (WHO) lack of any pandemic declaration through mid-May, despite heightened vigilance on ongoing threats. Recent hantavirus cases linked to the MV Hondius cruise ship from Argentina—now prompting CDC Level 3 advisories and detections in five U.S. states—have spurred brief market volatility, but official assessments emphasize low global risk due to primarily rodent-to-human transmission and rare human-to-human spread (limited to Andes strain). Mpox clade Ib multi-country outbreaks persist with 181,000+ confirmed cases globally since 2022 per WHO, yet fall short of pandemic thresholds without sustained respiratory spread. Bird flu (H5N1) shows no efficient human transmission despite animal reservoirs. Enhanced post-COVID surveillance from CDC and WHO underpins this positioning, with next epidemiological updates expected weekly; a novel pathogen with rapid, widespread human-to-human contagion remains the key unmet criterion.